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Mononuclear ruthenium(II) theranostic complexes
that function as broad-spectrum antimicrobials in
therapeutically resistant pathogens through
interaction with DNA†
Kirsty L. Smitten,ab Eleanor J. Thick,a Hannah M. Southam,b Jorge Bernardino de la
Serna,cd Simon J. Fosterb and Jim A. Thomas*a
Six luminescent, mononuclear ruthenium(II) complexes based on the tetrapyridophenazine (tpphz) and
dipyridophenazine (dppz) ligands are reported. The therapeutic activities of the complexes against Gram-
negative bacteria (E. coli, A. baumannii, P. aeruginosa) and Gram-positive bacteria (E. faecalis and S.
aureus) including pathogenic multi- and pan-drug resistant strains were assessed. Estimated minimum
inhibitory and bactericidal concentrations show the activity of the lead compound is comparable to
ampicillin and oxacillin in therapeutically sensitive strains and this activity was retained in resistant strains.
Unlike related dinuclear analogues the lead compound does not damage bacterial membranes but is still
rapidly taken up by both Gram-positive and Gram-negative bacteria in a glucose independent manner.
Direct imaging of the complexes through super-resolution nanoscopy and transmission electron
microscopy reveals that once internalized the complexes' intracellular target for both Gram-negative and
Gram-positive strains is bacterial DNA. Model toxicity screens showed the compound is non-toxic to
Galleria mellonella even at exposure concentrations that are orders of magnitude higher than the
bacterial MIC.
Introduction
Most medicinal research involving RuII polypyridyl complexes is
focused on their potential as anti-cancer therapeutics or – due
to their luminescent properties – imaging probes.1–7 Yet the rst
studies to investigate the medical potential of such species,
conducted in the 1950s by the Dwyer group, focused on their
antimicrobial effects.8,9 This work centered around mono-
nuclear, tris(bidentate), inert derivatives of the [Ru(phen)3]
2+-
cation (phen ¼ 1,10-phenanthroline) in which the effect of
lipophilicity on activity against bacteria was explored. The
parent compound investigated was shown to be inactive against
all bacteria strains investigated; however, the addition of methyl
groups improved this activity. This led to the identication of
a derivative that displayed promising activity against Gram-
positive bacteria strains. Yet, as this lead showed lower activi-
ties than commercial antibiotics of the time, no further devel-
opment in this area occurred for decades.
In the ensuing years, antimicrobial resistant (AMR) has
emerged as a growing global threat to public health.10–12 Infec-
tions with pathogens that display extensive and even pan-drug
resistance can lead to high mortality rates.13–15 Although
certain Gram-positive pathogens such as methicillin resistant
Staphylococcus aureus (MRSA),10,11 are much publicized as AMR
pathogens, in general, Gram-negative bacteria are a higher
priority problem.12,13 For example, other members of the
ESKAPE group of serious hospital acquired infections, such as
Pseudomonas Aeruginosa, Acinetobacter baumannii and members
of the Enterobacteriaceae, are Gram-negative and these latter
three bacteria have been identied as Priority 1 pathogens in
the recent WHO list for research and development.14
As treatment with last-line drugs, such as carbapenems,
increasingly fail15–18 the search for new antimicrobials has been
reinvigorated. In the context of this developing health crisis, the
potential of metal complexes,19–21 and in particular RuII systems,
as antimicrobials has recently been revisited.22 A common
strategy to enhance the activity of such entities is the
construction of oligonuclear structures related to the original
lead identied by Dwyer. For example, Collins and Keene, have
developed a series of oligonuclear analogues, in which the
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original [Ru(phen)3]
2+ d6-metal centers are tethered together by
exible methylene-based linkers of varying lengths. This
approach produced a set of complexes with considerably low-
ered MICs compared to mononuclear analogues.23 Although the
activity and imaging properties of these compounds have been
explored, their mechanism of action is still being investigated. A
recent report indicated that the ability of these compounds to
span the membrane may account for their antimicrobial
activity;24 however, another mode of action has also been
hypothesized. Intracellular polar accumulation of the
complexes has been attributed to binding to ribosomes causing
subsequent condensation of polysomes.25 Apart from two
mononuclear derivatives that are more active against Gram-
negative species, but are also cytotoxic toward eukaryotes,26,27
all these systems show their highest activity against Gram-
positive strains.
In ongoing studies, we have developed oligonuclear RuII
polypyridyl complexes as eukaryotic cell probes, as well as
therapeutics and theranostics for cancer cell lines.3,7,28,29 This
work led to the identication of a dinuclear system
[{Ru(phen)2}2(tpphz)]
4+, (phen ¼ 1,10-phenanthroline, tpphz ¼
tetrapyrido[3,2-a:20,30-c:300,200-h:2000,3000-j]phenazine) that can be
used as a DNA imaging probe for super-resolution STED
nanoscopy.30 More recently we have extended these studies to
produce more lipophilic derivatives of the STED probe that are
therapeutically active against bacterial pathogens. By incorpo-
rating ancillary ligands such as 3,4,7,8-tetramethyl-1,10-
phenanthroline, TMP, we synthesized complexes such as
[{Ru(TMP)2}2(tpphz)]
4+ that retained their low toxicity to
eukaryotic cells. Yet, in contrast to the complexes reported by
Collins and Keene and others these complexes display high
active against Gram-negative bacteria but are less active against
Gram-positive S. aureus. Studies revealed that these complexes
bind to and consequently damage Escherichia coli bacterial
membranes,31 although the therapeutic effect is less
pronounced in S. aureus due to binding to specic cationic
components of the Gram-positive cell wall.32
Herein, we report on the activity of mononuclear derivatives
of the dinuclear antimicrobial – Fig. 1. Surprisingly, we nd
these systems are highly active in both Gram-positive and Gram-
negative bacteria, we think this is due to the lower cationic
charge in comparison to the dinuclear derivative resulting in
increased compound uptake in Gram-positive strains. The most
promising lead is a broad band antimicrobial that, displays
high-activity even against multi-drug resistant pathogens but is
nontoxic toward the commonly employed insect model, Galleria
mellonella. By exploiting its intrinsic multimodal imaging
capabilities, we have conrmed that once internalized the
compound is active through binding to cellular DNA.
Results and discussion
Cell free studies
In previous studies, involving related complexes and eukaryotic
cells aimed at creating anticancer leads, it was found the
RuII(tpphz) fragment was vital for bioactivity, as changing the
ligand to dppz resulted in complete loss of activity toward
cancer cells.33,34 To investigate the importance of the tpphz
ligand on the potential antimicrobial activity of complexes 12+–
42+, dppz-based analogues, 52+ and 62+ were also synthesized.
Previously reported complexes 12+ and 52+ were synthesized
through an established procedure,35 complexes 22+, 32+, 42+ and
62+ were synthesized and characterized through related
methods36 – see ESI† for details. All these complexes were
synthesized as hexauorophosphate salts and converted to
chloride salts via anion metathesis for cell-free and in-cell
studies. In MeCN, the hexauorophosphate salts all display
the expected intense RuII/ tpphz 3MLCT emission centered at
z 670 nm and, as expected, the corresponding emission from
the chloride salts is greatly diminished in water.
Many previous studies have demonstrated the relationship
between lipophilicity and hydrophobicity as a factor in live-cell
uptake of bioactive substrates.12–15 Log P for all four tpphz
complexes – determined from octanol–water partition using the
shake ask procedure (Table 1) – reveals that none of the
compounds are truly lipophilic. However, a comparison of
Log P for 12+–62+ indicates that relative lipophilicity increases
with the number of methyl groups attached to the ancillary
ligand. In addition, the tpphz ligand increases lipophilicity of
the complexes relative to dppz.
As previous studies have reported 12+ binds to duplex DNA
with a high affinity33 – we investigated the interaction of 42+ and
DNA in cell-free conditions. On addition of CT-DNA, buffered
aqueous solutions of 42+ showed a distinctive increase in
Fig. 1 Structures of the mononuclear RuII complexes relevant to this
report.
Table 1 Log P data 12+–42+
Complex Log Pa
12+ 1.16
22+ 0.68
32+ 0.62
42+ 0.24
52+ 1.43
62+ 1.13
a Log octanol/water partition coefficients for each complex was
determined aer 20 h at 37 C.
This journal is © The Royal Society of Chemistry 2020 Chem. Sci., 2020, 11, 8828–8838 | 8829
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emission that is typical of a DNA light-switch effect which was
used to construct saturation binding curves – see ESI.†
Complexes that exhibit DNA light-switch properties have an
increase in emission intensity in solvent inaccessible environ-
ments due to vibrational/isomerization pathways being blocked
when the dyes bind to DNA. Fits of the data to the McGhee–von-
Hippel model for non-cooperative binding37 produced a binding
constant Kb: 2.2  10
7 M1 and site size of 2.5 base pairs.
Although this affinity is higher than the parent complex33 –
probably due to the enhanced hydrophobicity and extended
aromatic surfaces of 42+ – it is entirely consistent with values
obtained for other related metallo-intercalators such as
[{Ru(bpy)2}2(tpphz)]
4+ (Kb: 5  10
7 M1).34,38 Perhaps more
signicantly, its DNA binding affinity is an order of magnitude
higher than that of groove-binding [{Ru(TMP)2}2(tpphz)]
4+.31
Antimicrobial activity
In previous studies by the Thomas group, the cell uptake
properties of the dinuclear derivative [{Ru(TMP)2}2(tpphz)]
4+
were studied.31 It was found that it was readily internalized by
both Gram-positive (Staphylococcus aureus) and Gram-negative
(Escherichia coli) bacteria. In the present studies, all the
complexes were screened against a panel of Gram-positive and
Gram-negative bacteria, this specic panel was chosen as the
strains are all listed in The WHO Priority Pathogen list.
Gram-positive members of the initial panel comprised of
a gastrointestinal, vancomycin-resistant, strain of Enterococcus
faecalis (V583) and a non-pathogenic wild-type strain of S.
aureus, (SH1000). The Gram-negative species included a wild-
type E. coli (MG1655), and pathogenic ST131 E coli strain
(EC958), a multi-drug resistant strain of A. baumannii (AB184)
and a pan-drug resistant, clinical isolate strain of P. aeruginosa,
(PA2017) taken from a patient at the University of Surrey. EC958
was chosen as it is an emerging pathogen of concern which
causes urinary tract infections and exhibits high levels of multi-
drug resistance through production of CTX-M extended spec-
trum beta lactamase. V583 was selected for comparison as it
also causes urinary tract infections and exhibits resistance to
the antibiotic vancomycin.39–41
Both, A. baumannii and P. aeruginosa were selected as they
belong to WHO's Priority 1: critical class for developing new
antibiotics,14 and the PA2017 clinical isolate was found to be
pan-drug resistant. In addition, AB184 is the most prevalent
clonal group of A. baumannii in the United Kingdom. The
Minimum Inhibitory Concentration, MIC), of the six complexes
were obtained in both nutrient-limited glucose dened or
chemically dened minimal media (MM) and nutrient rich
Mueller-Hinton II (MH-II) – Table 2. This is the lowest
compound concentration required to inhibit bacterial cell
proliferation. Although nutrient-rich growth media, like MH-II,
are used as a standard in clinical assessments of antimicrobials,
nutrient limited environments represent relevant biological
conditions during different stages of infection in vivo. Apart
from V583 and SH1000, glucose dened MM was used but, as
Gram-positive bacteria cannot grow in these conditions,
chemically denedMMwas used for these bacteria. As observed
in previous studies, all the complexes show increased activity in
MM. This observation can be attributed to the complexes
interacting with components within the more chemically
complex MH-II media. Consistent with this hypothesis, at
highest concentrations (256–512 mg mL1) 22+ was seen to
precipitate out of MH-II.
Through the series of RuII(tpphz)-based complexes, an
increase in lipophilicity correlates with increased activity. This
trend – which is seen across all strains and is consistent with
studies on dinuclear analogues31 – results in the most lipophilic
compound, 42+, showing the highest activity. Interestingly, the
two dppz-based complexes, which exhibit a lower lipophilicity
than their tpphz analogues, display much higher MICs, even
Table 2 MIC (mM) results for E. coli (MG1655, EC958), E. faecalis (V583), P. aeruginosa (PA2017), A. baumannii (AB184) and S. aureus (SH1000) in
GDMM, CDM and MH-II, n ¼ 3
MG1655 EC958 V583 SH1000 PA2017 AB184
Dened medium values
12+ 17.5 34.9 69.8 69.8 34.9 17.5
22+ 33.9 33.9 135.6 33.9 16.9 16.4
32+ 8.2 16.5 65.8 32.9 16.4 8.5
42+ 3.9 3.9 31.1 7.8 7.8 7.8
52+ 344.2 344.2 688.4 688.4 688.4 344.2
62+ 303.4 303.4 606.8 303.4 606.8 606.8
Controla 5.0 >512 7.5 5.0 >512 >512
MH-II values
12+ 139.7 279.5 279.5 139.7 279.5 69.9
22+ 271.1 271.1 542.3 271.1 271.1 135.6
32+ 65.8 263.3 263.3 97.5 195.0 65.8
42+ 31.1 62.2 62.2 38.9 62.2 15.6
52+ 344.2 344.2 688.4 688.4 688.4 688.4
62+ 303.4 303.4 606.8 606.8 606.8 606.8
Controla 10.0 >512 5.0 5.0 >512 >512
a Control ¼ ampicillin except SH1000, where oxacillin was used.
8830 | Chem. Sci., 2020, 11, 8828–8838 This journal is © The Royal Society of Chemistry 2020
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when more lipophilic ancillary ligands are employed, illus-
trating that the RuII(tpphz) moiety is required for high activity.
Estimates of minimum bactericidal concentrations, MBC,
for 12+–62+ were also obtained, and this data is likewise
summarized in Table 3. This is lowest compound concentration
required to cause bacterial cell death. Trends are similar to the
MICs, in that the most lipophilic compounds have the lowest
MBC, resulting in 42+ showing a lower MBC against MG1655
than ampicillin in MM. An increase in MBC between MM and
MH-II is again observed. In dened media the MBC of all six
compounds lies within a 4-fold magnitude of the MIC and
therefore they can be classied as bactericidal. Again, as ex-
pected from the MIC data, 52+ and 62+ are not active. One
notable observation that emerged from these data is that, apart
from the vancomycin resistant E. faecalis strain, in which MIC/
MBC concentration are around 4 higher, complex 42+ shows
similar activity across the panel of bacteria, whether they are
Gram-positive or Gram-negative, therapeutically sensitive or
resistant. Indeed, the complex retains its high active against the
pan-drug resistant PA2017-strain of P. aeruginosa, which – even
in its wild-type form – is notoriously difficult to treat due to its
multiple resistance mechanisms.42 The activity against S. aureus
was particularly striking.
Our previous studies on the dinuclear analogue of 42+
showed that while it is very active against all Gram-negative
bacteria it has been tested against, including resistant patho-
gens, its activity against even the wild-type S1000 strain of S.
aureus is comparatively low. Furthermore, subsequent
screening against BH1CC, a mecA positive methicillin resistant
strain of S. aureus, revealed a further large decrease in bacteri-
cidal activity, indicating that S. aureus possesses innate and/or
acquired resistance to the complex.32
Time-kill assays were conducted to determine the rate of cell
death from CFU mL1 – Fig. 2 – OD600 time-kill assays given in
the ESI.†42+ caused a signicant cell death in EC958, MG1655
and SH1000 within 30 minutes of incubation. At concentrations
above the MIC, cell death is observed in all strains, with expo-
nential cell death occurring at the highest concentrations.
Concentration discrepancies between theMBC and the time-kill
assays can be accounted for by the different conditions of the
experiments, the MBC is conducted stationary in a 96-well plate
over 24 hours, whereas the time-kill is conducted with 90%
aeration and rotation over six hours.
Given that the MBC concentration of 42+ in SH1000 is
entirely comparable to those obtained with the tested Gram-
negative bacteria, we went on to investigate its activity in
a clinical isolate displaying AMR as well as the BH1CC MRSA
strain. These experiments led to MBC values of 7.8 mM and 11.7
mM respectively, indicating that, in stark contrast to its dinu-
clear analogue, even resistant strains of S. aureus display little or
no increased tolerance toward 42+. These observations further
indicate that the complex has a different action mechanism to
the dinuclear complexes. To further investigate this issue, we
used ICP-AES to explore internalization of 42+ by Gram-positive
and Gram-negative bacteria.
Cell uptake studies
First, experiments on the uptake of 42+ by pathogenic EC958
cells were conducted over an hour, as time-kill assay showed
bactericidal effects within this Gram-negative species over this
exposure time. Accumulation of ruthenium was measured by
ICP-AES in the absence and presence of glucose, Fig. 3, and iron
content of the cells (a trace element in all cells) was quantied
as a control. ICP-AES detects both intracellular accumulation
and strongly membrane–bound complexes.
Although negligible changes in CFU mL1 indicated that the
compound did not cause the cells to lyse during the experiment, in
the presence of glucose, an initial large accumulation of the
Table 3 MBC (mM) results for E. coli (MG1655, EC958), E. faecalis (V583), P. aeruginosa (PA2017), A. baumannii (AB184) and S. aureus (SH1000) in
GDMM, CDM and MH-II, n ¼ 3
MG1655 EC958 V583 SH1000 PA2017 AB184
Dened medium values
12+ 34.9 17.5 279.5 69.8 34.9 34.9
22+ 33.9 17.0 271.2 33.9 16.9 16.9
32+ 8.2 16.5 131.7 32.9 32.9 8.2
42+ 3.9 3.9 31.1 7.8 7.8 7.8
52+ 344.2 688.4 688.4 688.4 688.4 344.2
62+ 303.4 606.8 606.8 606.8 606.8 303.4
Controla 10.0 >512 7.5 10.0 >512 >512
MH-II values
12+ 139.7 297.5 558.9 297.5 297.5 69.9
22+ 542.3 271.2 542.3 542.3 271.1 135.6
32+ 131.7 131.7 263.4 131.7 195.0 65.8
42+ 62.2 124.5 124.5 62.2 62.2 38.9
52+ 344.2 688.4 688.4 688.4 688.4 344.2
62+ 303.4 606.8 606.8 606.8 606.8 303.4
Controla 10.0 >512 7.5 10.0 >512 >512
a Control ¼ ampicillin except SH1000 where oxacillin was used.
This journal is © The Royal Society of Chemistry 2020 Chem. Sci., 2020, 11, 8828–8838 | 8831
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complex was observed at both the 5- and 10 minute time-points,
followed by a drop in Ru content at 20 minutes. Interestingly, in
the absence of glucose, this efflux does not occur, suggesting an
energy-dependent transport mechanism is active in transporting
42+ out of cells. Although signicant differences in Ru content is
initially observed in the presence or absence of glucose, aer 60
minutes intracellular Ru content is virtually undifferentiated.
Similar to the time-kill assay, these observations suggest that cell
function is affected by 42+ within an hour of exposure.
Conversely, similar experiments with Gram-positive S. aureus
cells shows no evidence of efflux with rapid initial uptake being
observed in all conditions (see ESI†), so that peak intracellular
concentration of the complex is reached within 5 minutes.
More interestingly, a comparison on the uptake of 42+ with
its dinuclear complex, [{Ru(TMP)2}2(tpphz)]
4+, revealed that – in
the absence or presence of glucose – complex 42+ is taken up at
an approximately three times higher concentrations than its
dinuclear analogue (see ESI†). Again, this observation suggests
that the two complexes are internalized by bacteria through
different mechanisms. To investigate this issue further, tests on
membrane function in treated cells were carried out.
As an ATP release assay using the dinuclear compound had
previously revealed that it causes membrane damage within
both Gram-positive (S. aureus) and Gram-negative (E. coli)
bacteria,31,32 similar experiments were carried out with 42+ and
the EC958 strain of E coli – Fig. 4. Signicantly, when compared
with a compound-free control (0 MIC) and a positive control
using polymyxin (4 mg mL1), this membrane damage assay
revealed no signicant ATP release indicating that, unlike the
dinuclear parent compound, the mechanism of action of 42+
Fig. 3 Accumulation experiments. ICP-AES data for the uptake of
ruthenium by E. coli EC958 in the absence (a) and presence (b) of
glucose after exposure to 42+. Comparison between uptake in the
absence and presence of glucose at each time-point (c). Ru (blue) and
Fe (red) levels per cell are expressed as metal (g) per cell. Fe levels were
calculated as a control. Condition: concentration of 42+ ¼ 3.9 mM.
Cells were washed with 0.5%(v/v) nitric acid to remove unbound
complex. After washing the whole cell is dissolved for metal content
measurement. Error bars represent three independent biological
repeats  SD.
Fig. 4 ATP release membrane damage assay. Determination of 42+-
induced ATP released from E. coli EC958 cells. Extracellular [ATP] (nM)
quantified with recombinant luciferase and D-luciferin, with ATP
released measured on a luminometer for samples exposed to
0 (control), 1.95, and 3.9 mM (MIC) of 42+ over a period of two hours. A
3 star significant difference is observed between 0 and 1 MIC. Error
bars represent three biological repeats  SD.
Fig. 2 Time-kill kinetic assays. Complex 42+ induces dose-dependent
killing of E. coli EC958 (I), MG1655 (II) and SH1000 (III) planktonic
cultures in vitro. The complex was added at various concentrations
below and exceeding the MIC of 42+ in defined media (GDMM and
CDM). Killing was determined by monitoring the number of colony
forming units (CFU) per mL at time intervals up to 6 h post treatment.
Error bars represent three independent biological repeats  standard
deviation (SD).
8832 | Chem. Sci., 2020, 11, 8828–8838 This journal is © The Royal Society of Chemistry 2020
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does not involve membrane disruption. Interestingly, the
amount of extracellular ATP in the 42+ treated system is lower
than the control at all time points, vide infra. Retention of
intracellular ATP has been linked to DNA damage as cells
require more ATP when they are repairing their DNA. Further
support for this hypothesis came from studies on membrane
polarization.
The probe DiOC2(3) was used to determine whether 4
2+ has
an effect on membrane potential as its emission shis from
green to red on any increase in potential and the extent of the
shi is proportional to the membrane potential change – see
ESI.† Although bacteria treated with 42+ do produce some
detectable color change in the emission of DiOC2(3) it is far less
pronounced than observed for [{Ru(TMP)2}2(tpphz)]
4+,
providing evidence that the mononuclear complex has
a considerably less disruptive effect on bacterial membranes. To
probe the interaction of 42+ with bacteria in more detail a range
of imaging techniques were then employed.
Imaging studies
In a previous report, we demonstrated that this class of
compounds display excellent compatibility with super resolu-
tion microscopy techniques.5–7,22 Luminescence at specic
intracellular targets indicates localization of the complex as,
thanks to the DNA light-switch effect, emission from 42+ only
occurs when the compound is bound to solvent inaccessible
environments. Hence, structured illumination microscopy
(SIM) – which provides sub-diffraction limited resolutions of
100 nm (ref. 43) –was rst used to identify intracellular targets
of 42+ within EC958 cells.
As observed in Fig. 5, these images conrm that 42+ is readily
taken up by the EC958 strain of E. coli, with the compound
producing a distinctive localization pattern which is quite
different to that observed by [{Ru(TMP)2}2(tpphz)]
4+. Whereas
the dinuclear complex eventually localizes at the poles of E. coli
cells aer 20–30 minutes exposure, within 10 minutes of incu-
bation with 42+ a pattern of emission that is highly character-
istic of bacterial DNA staining is observed.
This hypothesis was conrmed by co-staining with the well-
established DNA-targeting, uorescent probe DAPI, which
resulted in a Pearson's coefficient of 0.69 for co-localization
with 42+ – see ESI.† Pearson's correlation coefficient is
measured from1 to +1, values of 0.7 and above are considered
a strong correlation, indicating an appreciable correlation
between DAPI and 42+. Using Alexa Fluor NHS-ester 405 –
a probe that is impermeable to non-compromised bacterial
membranes – the possibility that 42+ displays membrane
localization was also explored. These experiments showed no
correlation between the staining pattern of 42+ and NHS–ester
(see ESI†). This observation is consistent with the membrane
studies described above, and conrms that 42+ does not bind to,
or strongly interact with, the cell wall and membrane of
bacteria. The cellular localization properties of 42+ are strikingly
different from [{Ru(TMP)2}2(tpphz)]
4+ which is externally bound
in both Gram-negative and Gram-positive bacteria and only
internalizes aer inducing membrane damage.31
Taken together, the imaging studies and membrane assays
imply that complex 42+ is intrinsically cell permeant in both
Gram-positive and Gram-negative bacteria and, once internal-
ized, it preferentially binds to DNA.
The SIM images also provide further evidence that 42+ binds
to DNA within bacterial cells, as treated EC958 cells display
characteristic lamentous growth – Fig. 5. Whilst healthy E. coli
cells are typically 2.0 mm in length, aer an hour of exposure
treated cells display a 3 increase in cell length. Moreover, cells
exhibit multi-nucleation, these morphologies are commonly
observed on exposure to antibiotics, like ampicillin, that disrupt
DNA replication.44
As with E coli, treated Gram-positive bacteria reveal that DNA
is targeted by 42+ – Fig. 6. For example, 3D-surface plots of
treated S. aureus (SH1000) reveal maximum luminescent
Fig. 5 Super resolution microscopy – SIM – imaging, Z-stack 3D
projections. Localization of 42+ in E. coli EC958 cells visualized
through SIM at 10 min (I), 20 min (II), and 60 min (III). 3D luminescent
intensity surface plots are given for selected cells (a–c) showing peak
emission within the centre of the cell where DNA is localized. (IV) Cell
filamentation studies using the Image J measurement tool with cell
measurements given in mm. Cells imaged using the emission of 42+ on
excitation at 450 nm. After treatment with 3.6 mM 42+, cells were
washed with PBS before fixing with paraformaldehyde (4%).
This journal is © The Royal Society of Chemistry 2020 Chem. Sci., 2020, 11, 8828–8838 | 8833
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intensity at the centre of the bacterial cells where DNA is
localized. Colocalization with DAPI is again observed – Fig. 6 C–
E. In fact, a Pearson's coefficient of 0.895 provides even stronger
evidence of colocalization between 42+ and DAPI in S. aureus.
Although cell division and DNA replication are evident in these
images, they were taken at sub-MIC concentrations.
To probe DNA binding at higher resolutions 3D-STED
nanoscopy was employed – Fig. 7. Higher resolution tech-
niques were employed to see the DNA structure more clearly.
From the resultant images, intracellular DNA content at each
stage of cellular mitosis could be clearly visualized in dividing
cells, again conrming 42+ targets bacterial DNA. The difference
in localization between internalized 42+ and [{Ru(TMP)2}2(-
tpphz)]4+ can be attributed to the considerably higher DNA
binding affinity of the mononuclear complex compared to the
dinuclear complex.
Given that the complex binds to bacterial DNA, it was
postulated that this interaction is responsible for its therapeutic
action. Indeed, as noted in the previously described ATP release
assay (Fig. 4), bacteria treated with 42+ retained ATP even more
than the control. This is a known indicator of bacterial DNA
damage, as cells have a high demand for ATP as they repair such
damage.45
To assess whether exposure of EC958 cells to 42+ causes DNA
damage and mutagenesis, an Ames uctuation test was
employed – Fig. 8. The results were compared to natural
Fig. 7 Localization of 42+ in S. aureus SH1000 cells visualized through
laser scanning confocal microscopy, d-LCSM, (green, left) and stim-
ulated emission depletion nanoscopy, STED, (red, middle) and overlay
image (right) at; (A) 20 min, (B) 60 min and (C)120 min. Cells imaged
using the emission of 42+ on excitation at 470 nm with a white light
laser and a 470 nm notch filter. STED effect was obtained by
employing a 770 nm depletion laser, and a 780 nm vortex phase plate.
Both d-LCSM and d-STED images were processed using Hyugens
software (SVI). Cells were treated with the same conditions as Fig. 6.
Fig. 8 Ames test the fluctuation method. Percentage mutagenesis
was measured by treated cells with 42+ (0-2MIC) and incubating with
histidine. Bromocresol purple indicator was added, and the
percentage color change from purple to yellow measured after
incubation for 48 hours. A positive control with cells irradiated with
UV-light is added for comparison.
Fig. 6 Super resolution microscopy – SIM – imaging. Localization of
42+ in S. aureus SH1000 cells visualized through SIM at (A) 20 min and
(B) 60 min. (C–E) Co-staining localization of 42+ after 60 minutes
incubation. Following fixation with PFA (4%) cells were stained for 5
minutes with; (C) 42+; (D) DAPI (300 nm), (E), overlay of 42+ and DAPI
with colocalization scatter plot (F) 3D surface plot intensity for the co-
stain overlay for selected cells in white box shown in C–E. Cells
imaged using the emission of 42+ on excitation at 488 nm using A568
filter and the emission of DAPI on excitation at 405 nm using the DAPI
filter. After treatment with 3.6 mM 42+, cells were washed with PBS
before fixing with paraformaldehyde (4%).
8834 | Chem. Sci., 2020, 11, 8828–8838 This journal is © The Royal Society of Chemistry 2020
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mutagenic rates as a negative control and exposure to UV light
for 15 minutes as a positive control. Although treatment with
42+ does not produce effects as pronounced as those of UV-light,
the complex clearly induces increased DNA mutagenesis at its
MIC concentration and above, denoting that DNA damage plays
a role in its mechanism of action.
As transmission electron microscopy (TEM) provides yet
higher resolutions, this technique was also used to probe the
interaction of 42+ and bacterial DNA in both E. coli – Fig. 9 – and
S. aureus (ESI†). As 42+ incorporates an electron-dense RuII
center it functions as an EM contrast stain in itself; therefore,
conventional stains such as osmium tetroxide, or uranyl acetate
were not required in these studies. Hence, any intracellular
contrast staining in the gure is solely due to 42+, allowing its
localization to be directly visualized.
Whilst, these TEM images conrm the compound binds
cellular DNA, staining is also evident in the cytoplasm and at
the polar regions of the cell – Fig. 9. This full pattern of locali-
zation is not observed in optically-based images as – thanks to
the DNA light-switch effect – emission from 42+ only occurs
when it is bound in the solvent inaccessible environment
provided by DNA.
Interestingly aer 10 minutes of exposure, cell debris begins
to be observed – Fig. 9B–D. As the studies discussed above
indicate that 42+ is not active through membrane disruption,
this observation suggests that treated cells begin to die very
soon aer exposure. Aer 60 minutes many cells display
shrinkage. However, in contrast to its dinuclear equivalent
exposure to 42+ does not appear to cause cell lysis; although
contents have leaked from the dead cell – see Fig. 9C and D –
they still possess intact membranes, suggesting osmotic effects
cause the cytoplasmic shrinkage. Treated S. aureus cells also
exhibit similar morphology with cytoplasmic shrinkage and loss
of shape being observed – see ESI.†
Given these mononuclear complexes show high activity
against bacteria cell lines, their toxicity toward eukaryotes was
then explored. In this study the compounds were tested against
Galleria mellonella larvae, Fig. 10. As its physiology and immune
system is surprisingly similar to mammals this insect model is
increasingly employed as an in vivomodel, especially in toxicity
screening where it produces results that are comparable to
more commonly used mammalian models.46,47 A toxicity screen
conducted with 42+ used concentrations above the MIC in
complex media and at all concentrations the larvae survived for
the entire study (120 hours). Given an average larvae weight of
300 mg a concentration of 80 mg kg1 is 120 mg mL1.
In addition to live/dead scoring, activity tests and melani-
sation scores were determined – see ESI.† From these graphs it
is clear there is no difference in melanisation and activity in the
treated conditions relative to the controls. Melanisation only
began to occur at 72 hours, in a small percentage of larvae, and
they still remained active for the entire experiment. Like its
dinuclear parent complex, 42+ accumulates in the larval hemo-
lymph and this could even be conrmed by eye as the hemo-
lymph became distinctly dyed red at higher concentrations.
These experiments conrm that 42+ can be administered to
Galleria larvae at concentrations well above the required dose to
treat bacterial infections without any detectable deleterious
effects in this model organism.
Conclusions
In a medical context, the emergence of therapeutically resistant
pathogens is developing into a perfect storm.48–50 Aided by
Fig. 10 Kaplan–Meier survival curves. Determination of 42+toxicity in
the insectmodelGalleriamellonella. Larvaewere injectedwith 10 mL of
water (control), or 42+ (0–80 mg kg1, 0–120 mg mL1) The larvae
were incubated at 37.5 C and live/dead scores were conducted at 120
hours.Fig. 9 Transmission electron microscopy –TEM – imaging. Locali-
zation of 42+ in E. coli EC958 cells following treatment with MIC
concentrations of 42+ (A) 0 min control (B) 10 min after exposure (C),
60 min (D) 120 min. Cell leakage/debris is clearly revealed in B and C,
although the images in C and D reveal membranes that are still intact.
Cells were fixed with glutaraldehyde and the 0min control was stained
with osmium tetroxide, uranyl and led acetate. Bar¼ 1 mm in all images.
This journal is © The Royal Society of Chemistry 2020 Chem. Sci., 2020, 11, 8828–8838 | 8835
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overuse of antibiotics and more frequent international travel,
AMR has evolved and become globally disseminated, so that
multidrug and even pan-drug resistant pathogens are becoming
increasingly common. And yet, at the same time, the antibiotic
development pipeline has failed to identify new lead molecular
architectures. This situation is particularly acute for Gram-
negative infections as no new class of antibiotic has been
approved for these pathogens in over y years.51
It has been noted that while natural product-based treatments
for Gram-positive bacteria are relatively common, three out of the
four classes of broad-spectrum antibacterials effective against
Gram negative pathogens are derived from synthetic structures. It
has been suggested that this is because the structural require-
ments for broad spectrum activity are relatively incompatible with
the biosynthesis of natural products and, due to this, unnatural
synthetic systems should be investigated more closely.13,52 Metal
complexes like 42+ containing ligands with extended aromatic
systems meet many of the criteria determined to enhance uptake
into Gram-negative bacteria, in that they are polar, amphiphilic,
rigid, possess low globularity, and incorporate amine sites.33,34 In
fact, most of these criteria are also met by the previously reported
dinuclear analogues of 42+; yet, the activity of these complexes are
greatly lowered against Gram-positive pathogens such as thera-
peutically resistant S. aureus, whilst complex 42+ maintains its
activity even in an MRSA strain. This divergence is down to the
different uptake mechanisms of [{Ru(TMP)2}2(tpphz)]
4+ and 42+ by
Gram-positive bacteria. In wild type S. aureus the dinuclear
complex initially binds to the bacterial cell surface and only
internalizes 20 minutes aer exposure as a consequence of cell
membrane damage, but its uptake and therapeutic activity in
resistant MRSA strains is hampered by irreversible binding to
anionic teichoic and lipoteichoic acid residues which make up
a higher content of the cell wall in these strains.32 In contrast, it
seems the lower charged, more lipophilic, complex 42+ is
membrane permeant because it does not strongly interact with
such residues, but once internalized binds with high affinity to
bacterial DNA. As 42+ binds DNA and its closely related analogues
has shown phototoxic effects in eukaryotic cells it is expected the
compound may exhibit phototoxic antimicrobial activity. Future
work will look at studying the phototoxic antimicrobial effects
across a library of bacteria strains. In addition, we will use the
Galleria model to develop an in vivo antimicrobial efficacy prole.
It has been suggested that DNA is a promising but under-
exploited target for antimicrobials.53,54 Although a number of
organic and inorganic leads have been reported, only two DNA
binding antimicrobials, metronidazole55 and nitrofurantoin,56
are in current clinical use. In this context, the lead compound
described herein is particularly notable as it displays potent
broad-spectrum activity yet exhibits low toxicity to a eukaryotic
model.
An advantage of this relatively simple structure is its
synthetic accessibility. Recently reported derivatives of natural
products showing activities that are entirely comparable to 42+
are only available through intensive multi-step syntheses12,51,57
requiring specialized reagents that may be challenging to scale
up. Conversely, the modular synthesis of complex 42+ can be
accomplished from readily available starting materials in very
few steps, allowing facile scale-up. Using this approach,
a variety of derivatives of this structure, aimed at optimizing
activity, can easily be envisioned. Cell-based studies to investi-
gate the therapeutic action mechanism of 42+ and its derivatives
in more detail are underway and will form the basis of future
reports.
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